Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01597856 · ClinicalTrials.gov registry record · NA
Evaluation and Treatment of Substance Abuse in Veterans With PTSD Disability Claims
A NA study of Attendance at Treatment and PTSD, Substance Use, and Attendance at Treatment, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 346
- Enrollment target
- 2
- Study locations
NCT01597856: Completed NA study of Attendance at Treatment and PTSD, Substance Use, and Attendance at Treatment, sponsored by VA Office of Research and Development.
NCT01597856 is a NA study of Attendance at Treatment and PTSD, Substance Use, and Attendance at Treatment that has completed, run by VA Office of Research and Development. The registered enrollment target is 346 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01597856, a NA study of Attendance at Treatment and PTSD, Substance Use, and Attendance at Treatment, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 346 participants
- Enrollment target
- 2
- Study locations
Study Summary
Veterans can apply for compensation and pension (C \& P) benefits for a disability related to military service. The application exam for these benefits provides an opportunity for Veterans returning from service to access VA care. The investigators will recruit Veterans applying for C \& P to participate in this study. All enrolled participants will complete questionnaires around the time of their C \& P exam related to substance abuse, PTSD, service use, and attitudes. The investigators will monitor enrolled Veterans' attendance at treatment over time, and examine whether C \& P award, substance use, and beliefs about benefits are related to treatment attendance. Some enrolled participants will be assigned to one of two study groups: a treatment group and a no-additional-treatment group. People assigned to these groups will complete the same substance abuse, PTSD, service use, and attitudes questionnaires two additional times during the study. Participants assigned to the treatment group will receive information about the relationship between substance use and PTSD and will be referred to relevant treatment. The investigators will test whether Veterans who receive no-additional-treatment have different symptoms over time and attend less treatment sessions (mental health or substance abuse) than people assigned to treatment.
Primary Outcome
Mean number of weeks of substance abuse and/or mental health treatment attended (as measured by the Electronic Medical Record) by treatment group over time
Conditions Studied
Interventions
- BEHAVIORAL SBIRT
Study Locations (2)
Connecticut
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT - West Haven
Tennessee
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 346 participants |
| Start Date | 2013-03-18 |
| Est. Completion | 2017-12-31 |
| Phase | NA |
What the finished NCT01597856 record still lists
NCT01597856 is an interventional study that assigns participants to a tested intervention. The registered 346 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 2 conditions, with Attendance at Treatment appearing as the primary indexed condition, and to 1 intervention - of which SBIRT is the first listed.
NCT01597856 reports a single indexed study location in Connecticut, Tennessee.
Frequently Asked Questions
What is clinical trial NCT01597856 about?
NCT01597856 is a clinical study titled "Evaluation and Treatment of Substance Abuse in Veterans With PTSD Disability Claims". Veterans can apply for compensation and pension (C \& P) benefits for a disability related to military service. The application exam for these benefits provides an opportunity for Veterans returning from service to access VA care. The investigators will recruit Veterans applying for C \& P to partic...
What is the current status of trial NCT01597856?
This trial is currently completed. It is a NA study. The enrollment target is 346 participants. The study started on 2013-03-18. Estimated completion is 2017-12-31.
What conditions does trial NCT01597856 study?
This clinical trial studies the following conditions: Attendance at Treatment, PTSD, Substance Use, and Attendance at Treatment.
What interventions are being tested in trial NCT01597856?
The interventions under investigation include: SBIRT (BEHAVIORAL).
Who is sponsoring clinical trial NCT01597856?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01597856 being conducted?
This trial has 2 study locations across Connecticut, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01597856's enrollment target sits among peer trials
346 302nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05267886 · 346 participants · Phase 4
CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
- NCT06705842 · 346 participants · Phase 4
APPI-Cost Trial for Perforated Appendicitis
- NCT06932887 · 346 participants · Phase 3
The Beat Pain Better Trial
- NCT01742143 · 347 participants
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI